How DTC GLP-1s Improve Access But Hurt AdherenceByBrian Nowosielski,Brian Smith, PharmDOctober 5th 2026Brian Smith, PharmD, explains how direct-to-consumer GLP-1 pathways broaden initial access but endanger long-term patient adherence.